QIAGEN OmicSoft and Biomedical Knowledge Base

Exploring pan-cancer immunomodulators for biomarker discovery and validation using TCGA and public single-cell data

272 views
October 12, 2023
Cancer outcome is influenced by both the tumor microenvironment and host immune response. Using QIAGEN OmicSoft Studio to access public data from The Cancer Genome Atlas (TCGA) and our human Single Cell Lands collection, you’ll learn how to:

• View host immune response clusters across TCGA samples
• Identify differentially expressed immunomodulators across sample groups
• Visualize single-cell dimension reduction maps and overlay expression data
• Identify potential biomarkers whose expression correlates or anti-correlates with targets genes
• Validate new biomarkers using custom queries and TCGA survival data

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...

1,985 views July 19, 2022

High-quality biomedical relationships knowledge is the cornerstone of modern...

QIAGEN OmicSoft and Biomedical Knowledge Base

Supercharge your AI in drug discovery with high-quality biomedical data

652 views October 11, 2023

If you’re working in pharma or biotech, you likely rely on artificial...

QIAGEN OmicSoft and Biomedical Knowledge Base

Unlocking the power of API-based 'omics queries

591 views June 12, 2023

If you're a data scientist or bioinformatician working in biopharma, here's...

QIAGEN OmicSoft and Biomedical Knowledge Base

Integrating deeply curated omics data with APIs for biomarkers and drug-target investigation

479 views September 19, 2023

If you’re a data scientist or bioinformatician working in biopharma and need...